Reuters logo
BRIEF-Takeda, SGC in collaboration agreement related to inflammatory bowel disease
September 28, 2017 / 5:34 PM / 21 days ago

BRIEF-Takeda, SGC in collaboration agreement related to inflammatory bowel disease

Sept 28 (Reuters) - Takeda Pharmaceutical Co Ltd

* Takeda and SGC announce a collaboration agreement using patient tissue-based assays for clinical target validation in inflammatory bowel disease

* Takeda says ‍under terms of agreement, Takeda will provide funding for the research studies over a three-year period​

* Takeda - Agreement establishes translational medicine research team from Takeda, Karolinska University Hospital and ‍structural Genomics Consortium​ Source text: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below